Morgan Stanley’s Mineralys Therapeutics MLYS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.95M | Sell |
587,830
-31,918
| -5% | -$432K | ﹤0.01% | 3656 |
|
|
2025
Q1 | $9.84M | Buy |
619,748
+30,304
| +5% | +$481K | ﹤0.01% | 3353 |
|
|
2024
Q4 | $7.26M | Buy |
589,444
+73,631
| +14% | +$906K | ﹤0.01% | 3666 |
|
|
2024
Q3 | $6.25M | Buy |
515,813
+44,289
| +9% | +$536K | ﹤0.01% | 3799 |
|
|
2024
Q2 | $5.52M | Sell |
471,524
-50,485
| -10% | -$591K | ﹤0.01% | 3795 |
|
|
2024
Q1 | $6.74M | Sell |
522,009
-549,027
| -51% | -$7.09M | ﹤0.01% | 3666 |
|
|
2023
Q4 | $9.21M | Buy |
1,071,036
+936,364
| +695% | +$8.05M | ﹤0.01% | 3987 |
|
|
2023
Q3 | $1.28M | Buy |
134,672
+84,507
| +168% | +$804K | ﹤0.01% | 4649 |
|
|
2023
Q2 | $855K | Buy |
50,165
+20,114
| +67% | +$343K | ﹤0.01% | 4924 |
|
|
2023
Q1 | $471K | Buy |
+30,051
| New | +$471K | ﹤0.01% | 5290 |
|